Markwin Velders

Markwin Velders is the Managing Director and Owner of Prime Life Science, a company focused on (interim) management and consultancy in life science with special attention on technology starters. Markwin also holds positions as Member of the Supervisory Board at Amarna Therapeutics B.V. and ISA Pharmaceuticals. Additionally, Markwin is an Advisory Board Member at Thuja Capital and NECSTGEN, and an Entrepreneur In Residence at Oncode Institute. Markwin previously served as the Chairman Of The Board and board member at HollandBIO, and as VP Operations at Kite Pharma, Inc. Markwin has a PhD in Molecular Immunology from Leiden University and a Master of Science in Biomedical Sciences.